Min-Sung is one of the leading digital health experts in Europe and conducts later stage investments for Allianz Group which reaches 75mn customers in 80 countries worldwide. He helped to successfully set up the strategic growth fund that executes later stage and fund of fund investments. Prior to Allianz X he was a partner of a Berlin-based venture capital fund specialized in early stage digital health investments.
Min-Sung is passionate about opportunities in the healthcare sector and believes in both the immense value creation potential through digital technologies as well as the resulting positive impact on society.
Having been an entrepreneur before, he understands the challenges and difficulties of building up a company. With his blog, www.DigitalHealthVC.com, he hopes to serve as a helpful resource for digital health tech startups in the region. Min-Sung is also a contributing writer for mediums including TechCrunch and Tech.EU.
He has invested in startups and Venture Capital funds, including American Well, Neuronation, Mimi, and most notably mySugr – which was recently acquired by Roche.
Min-Sung studied Business Economics at Witten/Herdecke, Harvard, St.Gallen, and in Seoul.